- Home
- JCSE vs CNSP Comparison
JCSE vs CNSP Comparison
Compare JCSE & CNSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JCSE
- CNSP
- Stock Information
- Founded
- JCSE 1999
- CNSP 2017
- Country
- JCSE Singapore
- CNSP United States
- Employees
- JCSE N/A
- CNSP N/A
- Industry
- JCSE Miscellaneous manufacturing industries
- CNSP Biotechnology: Pharmaceutical Preparations
- Sector
- JCSE Consumer Discretionary
- CNSP Health Care
- Exchange
- JCSE Nasdaq
- CNSP Nasdaq
- Market Cap
- JCSE 5.6M
- CNSP 5.6M
- IPO Year
- JCSE 2022
- CNSP 2019
- Fundamental
- Price
- JCSE $1.20
- CNSP $1.25
- Analyst Decision
- JCSE
- CNSP Hold
- Analyst Count
- JCSE 0
- CNSP 1
- Target Price
- JCSE N/A
- CNSP N/A
- AVG Volume (30 Days)
- JCSE 728.1K
- CNSP 4.8M
- Earning Date
- JCSE 05-27-2025
- CNSP 05-27-2025
- Dividend Yield
- JCSE 7.63%
- CNSP N/A
- EPS Growth
- JCSE N/A
- CNSP N/A
- EPS
- JCSE 0.12
- CNSP N/A
- Revenue
- JCSE $14,723,999.00
- CNSP N/A
- Revenue This Year
- JCSE N/A
- CNSP N/A
- Revenue Next Year
- JCSE N/A
- CNSP N/A
- P/E Ratio
- JCSE $10.04
- CNSP N/A
- Revenue Growth
- JCSE N/A
- CNSP N/A
- 52 Week Low
- JCSE $0.67
- CNSP $0.77
- 52 Week High
- JCSE $2.39
- CNSP $800.00
- Technical
- Relative Strength Index (RSI)
- JCSE 53.91
- CNSP 44.20
- Support Level
- JCSE $0.99
- CNSP $1.06
- Resistance Level
- JCSE $1.55
- CNSP $2.90
- Average True Range (ATR)
- JCSE 0.23
- CNSP 0.20
- MACD
- JCSE 0.03
- CNSP 0.07
- Stochastic Oscillator
- JCSE 35.29
- CNSP 8.08
About JCSE JE Cleantech Holdings Limited
JE Cleantech Holdings Ltd is engaged in the manufacturing and selling of cleaning systems and other equipment that can be categorized into four different categories, namely aqueous washing systems, plating and cleaning systems, train cleaning systems, and other equipment, such as filtration units. The product lives of its cleaning systems and other equipment range from two to ten years. The company is also into designing, developing, and manufacturing other cleaning systems for various industrial end-use applications using its R&D and engineering capabilities. It derives a majority of its revenue from Singapore.
About CNSP CNS Pharmaceuticals Inc.
CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain.